Job Information
Boehringer Ingelheim Director /SAD, Medical Affairs Strategy Team Member (IPF/ILD) (Hybrid) in Ridgefield, Connecticut
Description
As an employee of Boehringer Ingelheim, you will actively contribute to the discovery, development, and delivery of our products to our patients and customers. Our global presence provides opportunity for all employees to collaborate internationally, offering visibility and opportunity to directly contribute to the companies' success. We realize that our strength and competitive advantage lie with our people. We support our employees in several ways to foster a healthy working environment, meaningful work, diversity and inclusion, mobility, networking, and work-life balance. Our competitive compensation and benefit programs reflect Boehringer Ingelheim's high regard for our employees.
The Medical Affairs Strategy [TA] Director is responsible to create the Medical strategic framework and prioritized Medical tactics to ensure the success of the respective BI product(s) from a Medical Affairs perspective, both prior to and leading up to launch as well as throughout the product lifecycle. This individual will exhibit strong understanding of the therapeutic area, the US healthcare landscape, the relevant clinical practice guidelines, and the emerging scientific data as well as the understanding of the overall TA aspirations and value drivers. The Medical Affairs Strategy Director will translate the TA priorities into an integrated strategic medical plan, tactics, and well-planned budgets that enable the successful medical affairs contribution to BI’s portfolio. In doing so, this individual will play a key role with corporate stakeholders, the US cross-functional partners, and the US Launch Teams in leading the co-creation of aligned strategic medical launch readiness; and work closely with the clinical development leads to ensure the successful integration of the US Medical insights and efforts where applicable. This individual will work with relevant stakeholders to identify the relevant external organized customer channels including the prioritized Health Systems and Payers to drive customized integrated medical plans and executable tactics for this customer segment. The Medical Affairs Strategy Director collaborates cross functionally and within the larger Clinical Development & Medical Affairs (CDMA) department (e.g., Medical Excellence, RWE, etc.) as well as across the organization (e.g., Marketing, Market Access, Analytics & Insights (A&I), HEOR, Clinical Operations, Patient Services, Legal, Compliance, etc.) and with global counterparts to create, execute, measure, and adapt the Medical Affairs strategy.
Drives the US collaboration with Corporate TA’s to create a consolidated medical strategy and integrated evidence plan for [X - TA] products/indications that prioritize innovation and address meaningful gaps internally and externally.
Leads the indication- or product-specific co-creation with corporate partners of the relevant Global Integrated Business Plans (IBPs) and ensure US strategic business needs are fully integrated into the global IBPs.
Duties & Responsibilities
Leads the creation of the respective US Medical Affairs Plans (MAP’s) and implement Launch Excellence tactics in Medical Affairs by driving robust TA medical dialogue with the Corporate TA stakeholders, the US Launch Lead, RWE, FBM, and Medical Excellence.
Effectively drives the execution of medical tactics, key data release activities, stay abreast of paradigm shifts in clinical practice, and align with BI / CDMA objectives, clinical development pipeline and the evolving US healthcare landscape.
Identify and promote synergies throughout the product lifecycle by influencing the US TAs, Corporate medical, the US TA franchise, Commercial operations, Go-To-Market (GTM), and CDMA leaders.
Proactively partner with the Medical Affairs Strategy Executive Director to ensure the seamless collaboration with the Clinical Development Lead and the Early Asset TA Lead to facilitate the full integration of the prioritized US clinical practice dynamics into the Clinical Development programs.
Drives success in TA launches and the timely execution of prioritized evidence generation programs in collaboration with Corporate Medicine TA and US franchise leadership.
Serves as a key representative in strategic discussions with TAs and CDMA Leadership regarding [X - TA] products to maximize business opportunities from a medical perspective, identify risks, assess the competitive landscape, and ensure appropriate collaboration occur with various business functions.
Leads the integration of insights, planning, execution, and analysis of evidence programs, creation and enhancement of content resources, maximizing medical communication channels and Strategic Engagement program with key experts, scientific leaders, and key institutions.
Ensure strategic congress planning, medical education, advisory boards, publication strategies, scientific advancement grants, and interface with professional societies relevant to the [X - TA] products.
Ensures availability of prioritized content, as well as develops and tracks the associated agreed measurable business outcomes. Proactively engages with Medical Customer Experience, A&I, and Capability Excellence teams to ensure seamless planning.
Actively contributes at and represents the CDMA TA team in internal business planning workshops and relevant strategic planning governance regarding [X - TA] products to ensure effective co-creation of appropriate, aligned, and integrated critical success factors, strategic imperatives, and their associated outcome measures (e.g., key performance indicators, metrics).
Leads proactive and ad hoc TA specific US projects to drive key strategic initiatives that facilitate business agility, customer focus and ensure compliance standards are met.
Leverage CDMA resources to create tailored tools and material to address organized customers, Payers/Systems in support of the Account Medical Advisors (AMA's).
Co-create an aligned strategic framework for organized customers in collaboration with the Value/Access and Health-Systems marketing teams. Ensure coordinated communication plan for Payers/Systems across the relevant internal stakeholders with emphasis on leading the medical affairs aspects of these plans.
Requirements
(SAD Level) Minimum of 5 years of experience within the pharmaceutical, clinical, healthcare, or equivalent industry with minimum 3+ years’ experience in Medical Affairs roles in the pharmaceutical industry
(Director Level) Minimum of 8 years of experience within the pharmaceutical, clinical, healthcare, or equivalent industry with minimum 5+ years’ experience in Medical Affairs roles in the pharmaceutical industry
Education Requirements:
Bachelor’s degree required, and in addition fulfill one of the following education levels:
Advanced degree (PharmD, NP, PA, Master’s, M.D., DO, Ph.D.)
OR
- Combined BSc. with a MBA, or BSN with a MBA
OR
- Other medically qualified licensure (e.g., RPh, Respiratory Therapist)
Eligibility Requirements:
Must be legally authorized to work in the United States without restriction.
Must be willing to take a drug test and post-offer physical (if required).
Must be 18 years of age or older.
Compensation
This position offers a base salary typically between $183,000 and $280,000 for SAD Level and $228,000 to $350,000 for Director level. The position may be eligible for a role specific variable or performance -based bonus and or other compensation elements. For an overview of our benefits please click here. (https://www.boehringer-ingelheim.com/us/careers/benefits-rewards)
All qualified applicants will receive consideration for employment without regard to a person’s actual or perceived race, including natural hairstyles, hair texture and protective hairstyles; color; creed; religion; national origin; age; ancestry; citizenship status, marital status; gender, gender identity or expression; sexual orientation, mental, physical or intellectual disability, veteran status; pregnancy, childbirth or related medical condition; genetic information (including the refusal to submit to genetic testing) or any other class or characteristic protected by applicable law.